MS: Busting the Myths
November 16, 2022 | Advocacy, Covid-19, Treatments
Important notice for MS patients regarding EvusheldTM. EvusheldTM is a pre-exposure prophylaxis, which has shown positive results for reducing the impacts of COVID-19 on those who may lowered immunity against COVID 19 due to their MS treatments. Evusheld is NOT […]
November 16, 2022 | Advocacy, Life with MS, Media
Recently, MSNZ made a submission to the Accessibility for New Zealanders Bill. The intention of the proposed bill is to establish “a new legislative framework that addresses systemic accessibility barriers that prevent disabled people, tāngata whaikaha and their whānau, and […]
November 9, 2022 | Advocacy, Media
This morning, 9th November 2022, MSNZs President, Neil Woodhams and petition submitter, Joan Perry made an oral presentation to the Health Select Committee calling for them to make aHSCT an available treatment option in NZ. It was live streamed on […]
September 14, 2022 | Advocacy, Treatments
Autologous Hematopoietic Stem Cell Treatment (aHSCT) is an intense chemotherapy treatment which aims to wipe out harmful immune cells and rebuild the immune system. aHSCT is a life-improving treatment halting the disease and disability in its tracks. A person receiving […]
September 14, 2022 | Advocacy, Progressive, Treatments
Currently, only approximately 1900 of the over 4130 New Zealanders diagnosed with MS are able to access funded Disease Modifying Therapies (DMTs). In particular, those with progressive forms of MS, Secondary (SPMS) and Primary Progressive MS (PPMS), have extremely limited […]